JF
IMRX icon

Jump Financial’s Immuneering IMRX Stock Holding History

Jump Financial’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63.4K Buy
12,700
+450
+4% +$2.28K ﹤0.01% 1931
2026
Q1 		$64.6K Buy
+12,250
New +$62.8K ﹤0.01% 1778
2022
Q2 		– Sell
-19,300
Closed -$125K – 1804
2022
Q1 		$125K Buy
+19,300
New +$185K 0.01% 1387

Other funds holding IMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Jump Financial's IMRX Position: Q2 2026 in Review

Jump Financial increased its Immuneering (IMRX) stake by 3.7% in Q2 2026, buying an estimated $2.28K and bringing the position to 12,700 shares worth $63.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1931.

Jump Financial first reported a position in IMRX in Q1 2022 and has held it in 3 quarters since. The position peaked at $125K in Q1 2022. 111 funds tracked by Wall St. Rank hold IMRX as of Q2 2026.

  • Jump Financial held 12,700 shares of Immuneering worth $63.4K as of Q2 2026.
  • Jump Financial bought 450 Immuneering shares in Q2 2026, an estimated $2.28K.
  • Immuneering made up ﹤0.01% of Jump Financial's portfolio in Q2 2026, its #1931 holding.
  • Jump Financial first reported a position in Immuneering in Q1 2022 and has held it in 3 quarters since.
  • Jump Financial's Immuneering position peaked at $125K in Q1 2022.
  • 111 funds tracked by Wall St. Rank held Immuneering as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.